Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: LAM561 With RT and TMZ for Adults With Glioblastoma [Phase 2, Phase 3]
Clinical trial update for LAM561 in combination with radiotherapy and temozolomide for adults with glioblastoma (Phase 2/Phase 3) shows the …
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM) [NA]
A clinical trial update describing a correlative study that analyzes magnetic resonance spectroscopy data alongside clinicobiological data i…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma [Phase 1]
A Phase 1 study is investigating a B7H3/IL13Ra2 bispecific armored CAR T-cell therapy for recurrent or refractory glioblastoma. The trial is…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma [EARLY_Phase 1]
An early-phase trial evaluates neoadjuvant chemoradiotherapy with or without concurrent azeliragon in newly diagnosed glioblastoma. The stud…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma
The clinical trial examining marrow and blood changes in glioblastoma patients is currently suspended.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry
Completed registry update for Vigilant Observation of Gliadel Wafer Implant Registry documenting the study status and findings to date.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma [NA]
This clinical trial update describes a study using magnetic resonance imaging to improve understanding of brain tumor biology in patients wi…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) [Phase 2]
INSIGhT is a Phase 2 clinical trial investigating individualized screening of innovative therapies for glioblastoma; recruitment is currentl…
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma [Phase 1]
Phase 1 trial evaluating oral gallium maltolate for relapsed and refractory glioblastoma; the study is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma [Phase 1]
Phase 1 clinical trial update for BRiTE, a bispecific T cell engager, being studied in glioblastoma.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM [Phase 1]
Phase 1 clinical trial evaluating a peptide-based tumor-associated antigen vaccine for glioblastoma, a malignant glioma. The study is curren…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas [Phase 1]
Phase 1 trial update for an Anti-GARP CAR-T cell therapy targeting recurrent Grade 2-4 gliomas (including glioblastoma), currently recruitin…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma [Phase 1]
Phase 1 trial evaluating peposertib with radiation therapy followed by temozolomide for newly diagnosed MGMT unmethylated glioblastoma or gl…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: NG101m Adjuvant Therapy in Glioblastoma Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial of NG101m as adjuvant therapy for glioblastoma is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme [Phase 3]
Phase 3 trial investigating intraoperative radiotherapy for newly diagnosed glioblastoma multiforme. The study is sponsored by Universitätsm…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of radiation therapy with a DLL3-targeting bispecific T-cell engager in DLL3-expres…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma [Phase 1]
Phase 1 clinical trial evaluating the combination of Laser Interstitial Thermal Therapy (LITT) with Lomustine (CCNU) for recurrent glioblast…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells [Phase 1, Phase 2]
A Phase 1/2 clinical study evaluating the relationship between metabolic MR-PET imaging and tissue glycolysis in infiltrating glioblastoma b…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma [Phase 1]
Phase 1 study of chlorotoxin-targeted CAR T cells targeting MMP2 in patients with recurrent glioblastoma and other recurrent gliomas. The tr…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma [Phase 2]
This clinical trial entry notes a Phase 2a study from Northwestern University evaluating ultrasound-based immune modulation for newly diagno…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Expanded Access program for AVM0703 is available to eligible patients with several solid tumor and blood cancer indications, including gliob…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma [Phase 1]
A Phase 1 clinical trial update exploring ibrutinib in combination with radiation and temozolomide for newly diagnosed glioblastoma; the stu…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Clinical and Treatment Determinant of Prognosis in Glioblastoma
Update on a clinical trial examining clinical and treatment determinants of prognosis in glioblastoma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread [Phase 2]
A Phase 2 clinical trial is evaluating intrathecal thiotepa added to Stupp treatment for glioblastoma with advanced spread, and the study is…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Memory Perception Assessment in Central/Non-central Nervous System Cancers [NA]
Clinical trial update on memory perception assessment in central and non-central nervous system cancers; the study includes glioblastoma and…